Revvity RVTY R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's R&D?
- Revvity (RVTY) reported R&D of $57.89M in Q1 2026.
- How has Revvity's R&D changed year-over-year?
- Revvity's R&D increased by 8.0% year-over-year, from $53.6M to $57.89M.
- What is the long-term trend for Revvity's R&D?
- Over 4 years (2021 to 2025), Revvity's R&D has grown at a -2.2% compound annual growth rate (CAGR), from $236.05M to $215.84M.
- What does R&D mean?
- The money spent on creating new products and improving existing technology.
- How do you interpret R&D?
- An increase signals a commitment to future innovation, whereas a sharp decrease might suggest a short-term focus on profitability at the expense of long-term growth.
- How does R&D compare across companies?
- Highly variable based on the company's stage in the product lifecycle; peers in biotech and diagnostics often maintain high R&D intensity.